Cargando…

Alterations in the Interleukin-1/Interleukin-1 Receptor Antagonist Balance Modulate Cardiac Remodeling following Myocardial Infarction in the Mouse

BACKGROUND: Healing after acute myocardial infarction (AMI) is characterized by an intense inflammatory response and increased Interleukin-1 (IL-1) tissue activity. Genetically engineered mice lacking the IL-1 receptor (IL-1R1-/-, not responsive to IL-1) or the IL-1 receptor antagonist (IL-1Ra, enha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abbate, Antonio, Salloum, Fadi N., Van Tassell, Benjamin W., Vecile, Elena, Toldo, Stefano, Seropian, Ignacio, Mezzaroma, Eleonora, Dobrina, Aldo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3225370/ https://www.ncbi.nlm.nih.gov/pubmed/22140485 http://dx.doi.org/10.1371/journal.pone.0027923

Ejemplares similares

Intracellular Function of Interleukin-1 Receptor Antagonist in Ischemic Cardiomyocytes
por: Vecile, Elena, et al.
Publicado: (2013)

Right Ventricular Dysfunction following Acute Myocardial Infarction in the Absence of Pulmonary Hypertension in the Mouse
por: Toldo, Stefano, et al.
Publicado: (2011)

Enhanced Interleukin-1 Activity Contributes to Exercise Intolerance in Patients with Systolic Heart Failure
por: Van Tassell, Benjamin W., et al.
Publicado: (2012)

Interleukin-1 Blockade in Acute Myocardial Infarction and Heart Failure: Getting Closer and Closer
por: Toldo, Stefano, et al.
Publicado: (2017)

Targeting the Innate Immune Response to Improve Cardiac Graft Recovery after Heart Transplantation: Implications for the Donation after Cardiac Death
por: Toldo, Stefano, et al.
Publicado: (2016)

Interleukin-18 mediates cardiac dysfunction induced by western diet independent of obesity and hyperglycemia in the mouse
por: Carbone, S, et al.
Publicado: (2017)

Low-Density Lipoprotein Receptor–Related Protein-1 Is a Therapeutic Target in Acute Myocardial Infarction
por: Toldo, Stefano, et al.
Publicado: (2017)

Interleukin-1 blockade with RPH-104 in patients with acute ST-elevation myocardial infarction: study design and rationale
por: Samsonov, M., et al.
Publicado: (2021)

Preservation of Contractile Reserve and Diastolic Function by Inhibiting the NLRP3 Inflammasome with OLT1177(®) (Dapansutrile) in a Mouse Model of Severe Ischemic Cardiomyopathy Due to Non-Reperfused Anterior Wall Myocardial Infarction
por: Aliaga, Joseph, et al.
Publicado: (2021)

NLRP3 Inflammasome Inhibitors in Cardiovascular Diseases
por: Mezzaroma, Eleonora, et al.
Publicado: (2021)

Amyloid formation disrupts the balance between interleukin-1β and interleukin-1 receptor antagonist in human islets
por: Hui, Queenie, et al.
Publicado: (2017)

Effect of interleukin-1 blockade with anakinra on leukocyte count in patients with ST-segment elevation acute myocardial infarction
por: Del Buono, Marco Giuseppe, et al.
Publicado: (2022)

Inhibition of Apoptosis Signal–Regulating Kinase 1 Reduces Myocardial Ischemia–Reperfusion Injury in the Mouse
por: Toldo, Stefano, et al.
Publicado: (2012)

Interleukin‐38 alleviates cardiac remodelling after myocardial infarction
por: Wei, Yuzhen, et al.
Publicado: (2019)

Comparative Cardiac Toxicity of Anthracyclines In Vitro and In Vivo in the Mouse
por: Toldo, Stefano, et al.
Publicado: (2013)

Interleukin 1-β, Interleukin-1 Receptor Antagonist, and Interleukin 18 in Children with Acute Spontaneous Urticaria
por: Machura, E., et al.
Publicado: (2013)

The interleukin-1 receptor antagonist influences interleukin-1 effects in rat and mouse
por: Bjrök, P., et al.
Publicado: (1992)

Interleukin Expression after Injury and the Effects of Interleukin-1 Receptor Antagonist
por: Chamberlain, Connie S., et al.
Publicado: (2013)

Interleukin-1 antagonists in Mevalonate Kinase Deficiency
por: Galeotti, C, et al.
Publicado: (2011)

Physiologic role of interleukin-1 receptor antagonist
por: Arend, William P, et al.
Publicado: (2000)

Interleukin-1 Antagonists for the Treatment of Recurrent Pericarditis
por: Abadie, Bryan Q., et al.
Publicado: (2022)

The systemic deletion of interleukin-1α reduces myocardial inflammation and attenuates ventricular remodeling in murine myocardial infarction
por: Lugrin, J., et al.
Publicado: (2023)

The interleukin-1 cluster, dyslipidaemia and risk of myocardial infarction
por: Keavney, Bernard
Publicado: (2010)

Interleukin 1-β, interleukin-1 receptor antagonist and vitamin D levels in children with atopic dermatitis
por: Machura, Edyta, et al.
Publicado: (2018)

Interleukin-1 and the NLRP3 Inflammasome in Pericardial Disease
por: Vecchié, Alessandra, et al.
Publicado: (2021)

Interleukin‐37 and Dendritic Cells Treated With Interleukin‐37 Plus Troponin I Ameliorate Cardiac Remodeling After Myocardial Infarction
por: Zhu, Ruirui, et al.
Publicado: (2016)

Interleukin‐1 Blockade Inhibits the Acute Inflammatory Response in Patients With ST‐Segment–Elevation Myocardial Infarction
por: Abbate, Antonio, et al.
Publicado: (2020)

Role of interleukin-25 in development of spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice
por: Abe, Yasuharu, et al.
Publicado: (2017)

Association of Interleukin-1 Beta and Interleukin-1 Receptor Antagonist Gene Polymorphisms and Plasma Levels with Diabetic Nephropathy
por: Liao, Xueling, et al.
Publicado: (2022)

Interleukin-2/Anti-Interleukin-2 Immune Complex Attenuates Cardiac Remodeling after Myocardial Infarction through Expansion of Regulatory T Cells
por: Zeng, Zhipeng, et al.
Publicado: (2016)

Endothelial Cell E- and P-Selectin and Vascular Cell Adhesion Molecule-1 Function as Signaling Receptors
por: Lorenzon, P., et al.
Publicado: (1998)

Production of interleukin-1 receptor antagonist by human articular chondrocytes
por: Palmer, Gaby, et al.
Publicado: (2002)

Interleukin-1 Receptor Antagonist Isoforms in Collagen-Induced Arthritis
por: Gabay, Cem, et al.
Publicado: (2000)

Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer
por: Gong, Zhenqiang, et al.
Publicado: (2018)

Roles of Interleukin-1 Receptor Antagonist in Prostate Cancer Progression
por: Fan, Yu-Ching, et al.
Publicado: (2020)

Interleukin-1 Receptor Antagonist as Therapy for Traumatic Brain Injury
por: Lindblad, Caroline, et al.
Publicado: (2023)

Cytokine pattern in patients with ST-elevation myocardial infarction treated with the interleukin-6 receptor antagonist tocilizumab
por: Woxholt, Sindre, et al.
Publicado: (2023)

Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment
por: Lewis, Anne M, et al.
Publicado: (2006)

Association between Polymorphism of Interleukin-1beta and Interleukin-1 Receptor Antagonist Gene and Asthma Risk: A Meta-Analysis
por: He, Yuanzhou, et al.
Publicado: (2015)

Preferential Production of Interleukin‐1β over Interleukin‐1 Receptor Antagonist Contributes to Proliferation and Suppression of Apoptosis in Leukemic Cells
por: Furukawa, Yusuke, et al.
Publicado: (1995)

Cannot write session to /tmp/vufind_sessions/sess_6jrbg9ip9s07lrp10bep766m9p